01/10/2022
https://www.congress.gov...
"I went through a litany in my opening statements of the deficiencies in what FDA committed to and what they missed."
"The faster, more predictable, and more accountable the programs are, the more patients stand to benefit from lifesaving, innovative drugs and devices."
"I will tell you right now, Congress is going to require accountability in the new program."
"What does it mean for a small company when FDA misses these goals, and what does it mean to patients?"